Bilton, Edward J. http://orcid.org/0000-0003-4293-1981
Coath, Fiona
Patil, Ajay
Jones, Colin
O’Sullivan, Eoin
Hingorani, Melanie http://orcid.org/0000-0002-0370-1764
Mukhtyar, Chetan
Mollan, Susan P. http://orcid.org/0000-0002-6314-4437
Funding for this research was provided by:
Roche
UCB | UCB UK
Invex Therapeutics Gensight Heidelberg engineering Chugai-Roche Ltd Allergan Santen Chiesi Santhera
Article History
Received: 26 April 2023
Revised: 24 May 2023
Accepted: 25 May 2023
First Online: 21 June 2023
Competing interests
: EO reports honoraria from Roche and UCB. SPM reports consultancy fees from Invex Therapeutics; advisory board fees from Invex Therapeutics and Gensight; and speaker fees from Heidelberg Engineering, Chugai-Roche Ltd, Allergan, Santen, Chiesi and Santhera. No other authors declare any conflicts of interest.